Role of biomarkers in diagnostics, stratification of risk and prognosis of heart failure
| Autor: | L. V. Sapozhnychenko, О. О. Khanyukov |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
heart failure biomarkers diagnostics prognosis business.industry lcsh:R heart failure biomarkers lcsh:Medicine General Medicine Disease diagnostics prognosis medicine.disease Diagnostic strategy Timely diagnosis Pathognomonic Heart failure Risk stratification Medicine business Intensive care medicine |
| Zdroj: | Медичні перспективи; Том 23, № 2(part1) (2018); 56-63 Medicni perspektivi (Medical perspectives); Том 23, № 2(part1) (2018); 56-63 Medičnì Perspektivi, Vol 23, Iss 2(part1), Pp 56-63 (2018) |
| ISSN: | 2307-0404 |
| DOI: | 10.26641/2307-0404.2018.2(part1).129517 |
| Popis: | Heart failure occupies one of the leading places in the structure of the causes of adult mortality in the world. The issues of timely diagnosis and prognosis of the outcomes of this disease do not lose their relevance due to the high heterogeneity of clinical manifestations and absence of absolutely pathognomonic symptoms. The development of the multimarker diagnostic strategy for management of patients with heart failure is a progressive approach .The review focuses on the synthesis of known evidence data on the role of biomarkers in diagnostics and risk stratification. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|